The attachment of multiple ubiquitin (Ub) moieties to a protein is referred to as polyubiquitination, and serves as a signaling mechanism for degradation of the selected protein. The rate of protein degradation is altered in cases of alcoholic liver disease, and the objective of this research proposal is to investigate the effects of pathological concentrations of 4-hydroxynonenal (4-HNE) on the polyubiquitination of intracellular hepatocyte proteins. This particular aldehyde has been selected due to its implication in multiple pathologies (e.g. atherosclerosis and reperfusion injury) through its ability to covalently modify proteins. The experiments proposed within have been designed to test the general working hypothesis that 4-HNE modulates the rate of protein polyubiquitination through direct modification of the substrate protein. The first phase of this research plan entails the selection of model proteins for investigating protein polyubiquitination in an in vitro system, and the effect of adduct formation between these proteins and 4- HNE on this process. The foundation provided by these early experiments will allow for the characterization of 4-HNE adducts formed with the model proteins, followed by the identification of ubiquitin-binding sites and the respective interaction of 4-HNE with these sites. Finally, the balance between ubiquitination and deubiquitination as influenced by 4-HNE will be assessed. When complete, the data provided by this research will provide further insight into the mechanisms by which 4-HNE exerts toxicity. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Predoctoral Individual National Research Service Award (F31)
Project #
1F31AA014308-01
Application #
6646320
Study Section
Special Emphasis Panel (ZAA1-GG (01))
Program Officer
Gentry, Thomas
Project Start
2003-06-01
Project End
2006-05-31
Budget Start
2003-06-01
Budget End
2004-05-31
Support Year
1
Fiscal Year
2003
Total Cost
$22,718
Indirect Cost
Name
University of Colorado Denver
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Roede, James R; Carbone, David L; Doorn, Jonathan A et al. (2008) In vitro and in silico characterization of peroxiredoxin 6 modified by 4-hydroxynonenal and 4-oxononenal. Chem Res Toxicol 21:2289-99
Carbone, David L; Doorn, Jonathan A; Kiebler, Zachary et al. (2005) Cysteine modification by lipid peroxidation products inhibits protein disulfide isomerase. Chem Res Toxicol 18:1324-31
Carbone, David L; Doorn, Jonathan A; Kiebler, Zachary et al. (2005) Modification of heat shock protein 90 by 4-hydroxynonenal in a rat model of chronic alcoholic liver disease. J Pharmacol Exp Ther 315:8-15
Carbone, David L; Doorn, Jonathan A; Kiebler, Zachary et al. (2004) Inhibition of Hsp72-mediated protein refolding by 4-hydroxy-2-nonenal. Chem Res Toxicol 17:1459-67
Carbone, David L; Doorn, Jonathan A; Petersen, Dennis R (2004) 4-Hydroxynonenal regulates 26S proteasomal degradation of alcohol dehydrogenase. Free Radic Biol Med 37:1430-9